Pfizer’s Clinical Data Puts the US One Step Closer to a COVID-19 Vaccine for Younger Kids
A Food and Drug Administration review this week determined that Pfizer/BioNTech’s COVID-19 vaccine is safe and effective for children ages 5 to 11, paving the way for a shot to be authorized for that age group as soon as early November. Awesome!
Photo Credit: Jon Tyson